Therefore data from clinical HNSCC patients also demonstrate that PTHLH might regulate tumor growth through cell cycle regulators, namely, CCNA2, CCNE2, and CDC25A (Fig. 6E). This evidence concerns the gene CCNE2 and head and neck squamous cell carcinoma.